TransCode Therapeutics In... (RNAZ)
NASDAQ: RNAZ
· Real-Time Price · USD
10.97
-0.08 (-0.72%)
At close: Aug 15, 2025, 3:59 PM
10.73
-2.19%
After-hours: Aug 15, 2025, 05:33 PM EDT
TransCode Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -25.51M | -16.75M | -14.93M | -17.91M | -17.06M | -18.55M | -19.59M | -18.58M | -18.91M | -17.56M | -15.23M | -13.27M | -5.83M | -6.84M | -4.85M | -3.89M | -6.79M |
Depreciation & Amortization | 444.38K | 534.86K | 552.17K | 563.44K | 558.19K | 516.75K | 406.08K | 292.1K | 177.2K | 98.61K | 98.09K | 80.82K | 62.82K | 42.47K | 13.48K | 5.95K | 1.25K |
Stock-Based Compensation | 1.67M | 1.7M | 1.84M | 2.03M | 1.06M | 1.04M | 857.13K | 570.4K | 493.52K | 395.33K | 303.77K | 262.22K | 198.14K | 186K | 159.66K | 126.99K | 93.18K |
Other Working Capital | -457.29K | -575.01K | -1.44M | -229.2K | 494.79K | 213.96K | 497.51K | 1.19M | 1.11M | 1.76M | 1.99M | -285.7K | -1.29M | -1.85M | -2.39M | -82.41K | -342.35K |
Other Non-Cash Items | 11.68M | 3.59M | 4.74M | 3.58M | 4.73M | 3.01M | 1.31B | 1.31B | 1.31B | 1.31B | 1.09M | 1.05M | 801.54K | 39.47K | 392.52K | 1.53M | 1.51M |
Deferred Income Tax | n/a | n/a | -2.68M | -1.52M | -3.58M | -3.01M | -1.31B | -1.31B | -1.31B | -1.31B | -262.84K | -261.5K | -3.11M | 876.19K | 873.11K | 871.77K | 3.98M |
Change in Working Capital | 128.74K | -351.48K | -3.32M | -133.97K | -2.06M | -1.08M | 1.9M | 372.75K | 1.91M | 1.31M | 1.45M | 932.97K | -39.04K | 432.39K | -514.72K | 372.19K | 201.27K |
Operating Cash Flow | -12.5M | -13.34M | -15.85M | -15.45M | -17.5M | -18.07M | -16.43M | -17.35M | -16.33M | -15.76M | -13.34M | -11.99M | -8.69M | -5.27M | -3.92M | -984.48K | -996.99K |
Capital Expenditures | -17.93K | -21.76K | 14.35K | 22.61K | 9.06K | n/a | -63.82K | -59.22K | -83.16K | -100.92K | -158.43K | -229.98K | -210.18K | -254.82K | -169.09K | -97.54K | -75.3K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 3K | 3K | 3K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -3.84K | -35.61M | -35.61M | -35.61M | -48.51M | -113.78M | -113.78M | -113.78M | -131.55M | -30.65M | -30.65M | -30.65M | 3K | n/a | n/a | n/a |
Investing Cash Flow | -17.93K | -21.76K | -35.59M | -35.59M | -35.6M | -35.61M | -63.82K | -59.22K | -83.16K | -100.92K | -155.43K | -226.98K | -207.18K | -251.82K | -169.09K | -97.54K | -75.3K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 190K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | 135.8K | n/a | n/a | 225.82K | -135.8K | 5.98K | 11.97K | -204.36K | 25.58M | 25.65M | 25.52M | 25.49M | -126.24K | -205.08K |
Financial Cash Flow | 19.17M | 16.4M | 10.3M | 15.24M | 20.82M | 15.91M | 15.16M | 7.54M | 1.19M | 11.97K | -204.36K | 25.58M | 25.65M | 25.52M | 25.49M | -126.24K | -15.08K |
Net Cash Flow | 6.66M | 3.04M | -5.58M | -217.92K | 3.29M | -2.2M | -1.34M | -9.87M | -15.23M | -15.86M | -13.71M | 13.36M | 16.75M | 20M | 21.4M | -1.21M | -1.09M |
Free Cash Flow | -12.51M | -13.36M | -15.84M | -15.42M | -17.49M | -18.07M | -16.49M | -17.41M | -16.41M | -15.86M | -13.5M | -12.22M | -8.9M | -5.52M | -4.09M | -1.08M | -1.07M |